Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1990 Apr;34(4):671–673. doi: 10.1128/aac.34.4.671

Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.

C Betriu 1, E Campos 1, C Cabronero 1, C Rodriguez-Avial 1, J J Picazo 1
PMCID: PMC171666  PMID: 2344174

Abstract

A total of 94 clinical isolates of the Bacteroides fragilis group was tested for susceptibility to metronidazole, chloramphenicol, clindamycin, cefoxitin, cefotetan, cefmetazole, moxalactam, mezlocillin, amoxicillin-clavulanic acid, and imipenem. All the strains tested were susceptible to imipenem, metronidazole, amoxicillin-clavulanic acid, and chloramphenicol. The rate of resistance to clindamycin was 21%. The results of this study demonstrate a difference in resistance rates from one species of the B. fragilis group to another.

Full text

PDF
672

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bawdon R. E., Rozmiej E., Palchaudhuri S., Krakowiak J. Variability in the susceptibility pattern of Bacteroides fragilis in four Detroit area hospitals. Antimicrob Agents Chemother. 1979 Nov;16(5):664–666. doi: 10.1128/aac.16.5.664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bourgault A. M., Harding G. K., Smith J. A., Horsman G. B., Marrie T. J., Lamothe F. Survey of anaerobic susceptibility patterns in Canada. Antimicrob Agents Chemother. 1986 Nov;30(5):798–801. doi: 10.1128/aac.30.5.798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bourgault A. M., Lamothe F. In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group. J Antimicrob Chemother. 1986 May;17(5):593–603. doi: 10.1093/jac/17.5.593. [DOI] [PubMed] [Google Scholar]
  4. Bourgault A. M., Rosenblatt J. E. Characterization of anaerobic gram-negative bacilli by using rapid slide tests for beta-lactamase production. J Clin Microbiol. 1979 Jun;9(6):654–656. doi: 10.1128/jcm.9.6.654-656.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brown E. M. The in-vitro susceptibility of the Bacteroides fragilis group to amoxycillin-clavulanic acid. J Antimicrob Chemother. 1984 Oct;14(4):367–372. doi: 10.1093/jac/14.4.367. [DOI] [PubMed] [Google Scholar]
  6. Cuchural G. J., Jr, Malamy M. H., Tally F. P. Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis. Antimicrob Agents Chemother. 1986 Nov;30(5):645–648. doi: 10.1128/aac.30.5.645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cuchural G. J., Jr, Tally F. P., Jacobus N. V., Aldridge K., Cleary T., Finegold S. M., Hill G., Iannini P., O'Keefe J. P., Pierson C. Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation. Antimicrob Agents Chemother. 1988 May;32(5):717–722. doi: 10.1128/aac.32.5.717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cuchural G. J., Jr, Tally F. P., Jacobus N. V., Gorbach S. L., Aldridge K., Cleary T., Finegold S. M., Hill G., Iannini P., O'Keefe J. P. Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982. Antimicrob Agents Chemother. 1984 Aug;26(2):145–148. doi: 10.1128/aac.26.2.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. De Almeida A. E., De Uzeda M. Susceptibility to five antimicrobial agents of strains of the Bacteroides fragilis group isolated in Brazil. Antimicrob Agents Chemother. 1987 Apr;31(4):617–618. doi: 10.1128/aac.31.4.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Derriennic M., Dubreuil L., Reynaud A. E., Courtieu A. L. Comparative in vitro activities of four macrolides: josamycin, erythromycin, spiramycin and roxithromycin, against 424 anaerobic bacteria. Chemioterapia. 1987 Jun;6(2 Suppl):159–160. [PubMed] [Google Scholar]
  11. Dias M. B., Jacobus N. V., Gorbach S. L., Tally F. P. In vitro activity of cefbuperazone against Bacteroides spp. Antimicrob Agents Chemother. 1985 Jun;27(6):968–970. doi: 10.1128/aac.27.6.968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dubreuil L., Derriennic M., Sedallian A., Romond C., Courtieu A. L. Evolution in antibiotic susceptibility of Bacteroides fragilis group strains in France based on periodic surveys. Infection. 1989 May-Jun;17(3):197–200. doi: 10.1007/BF01644030. [DOI] [PubMed] [Google Scholar]
  13. Dubreuil L., Devos J., Neut C., Romond C. Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics. Antimicrob Agents Chemother. 1984 Jun;25(6):764–766. doi: 10.1128/aac.25.6.764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Edmiston C. E., Jr, Krepel C. J., Clausz J. C., Condon R. E. Comparative in vitro beta-lactam activity against aerobic and anaerobic surgical isolates. Diagn Microbiol Infect Dis. 1988 Feb;9(2):105–113. doi: 10.1016/0732-8893(88)90103-4. [DOI] [PubMed] [Google Scholar]
  15. Goldstein E. J., Citron D. M. Comparative in vitro activities of amoxicillin-clavulanic acid and imipenem against anaerobic bacteria isolated from community hospitals. Antimicrob Agents Chemother. 1986 Jan;29(1):158–160. doi: 10.1128/aac.29.1.158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jenkins S. G., Birk R. J., Zabransky R. J. Differences in susceptibilities of species of the Bacteroides fragilis group to several beta-lactam antibiotics: indole production as an indicator of resistance. Antimicrob Agents Chemother. 1982 Oct;22(4):628–634. doi: 10.1128/aac.22.4.628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lamothe F., Fijalkowski C., Malouin F., Bourgault A. M., Delorme L. Bacteroides fragilis resistant to both metronidazole and imipenem. J Antimicrob Chemother. 1986 Nov;18(5):642–643. doi: 10.1093/jac/18.5.642. [DOI] [PubMed] [Google Scholar]
  18. Reig M., Campello M. G., Baquero F. Epidemiology of clindamycin resistance in the Bacteroides fragilis group. J Antimicrob Chemother. 1984 Dec;14(6):595–603. doi: 10.1093/jac/14.6.595. [DOI] [PubMed] [Google Scholar]
  19. Salaki J. S., Black R., Tally F. P., Kislak J. W. Bacteroides fragilis resistant to the administration of clindamycin. Am J Med. 1976 Mar;60(3):426–428. doi: 10.1016/0002-9343(76)90759-2. [DOI] [PubMed] [Google Scholar]
  20. Soriano F., Ponte C., Wilhelmi I. Increasing incidence of clinical isolates of Bacteroides fragilis resistant to clindamycin. J Antimicrob Chemother. 1984 Apr;13(4):395–395. doi: 10.1093/jac/13.4.395. [DOI] [PubMed] [Google Scholar]
  21. Sosa A., Tally F. P., Jacobus N. V., Gorbach S. L. Bacteroides fragilis resistance to clindamycin in vitro. Antimicrob Agents Chemother. 1982 Nov;22(5):771–774. doi: 10.1128/aac.22.5.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tally F. P., Cuchural G. J., Jr, Jacobus N. V., Gorbach S. L., Aldridge K., Cleary T., Finegold S. M., Hill G., Iannini P., O'Keefe J. P. Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States. Antimicrob Agents Chemother. 1985 Nov;28(5):675–677. doi: 10.1128/aac.28.5.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Werner H. Inhibitory activity of cefotetan and other beta-lactams against anaerobes. J Antimicrob Chemother. 1983 Jan;11 (Suppl):107–115. doi: 10.1093/jac/11.suppl_a.107. [DOI] [PubMed] [Google Scholar]
  24. Wexler H. M., Finegold S. M. In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria. Antimicrob Agents Chemother. 1988 Mar;32(3):403–406. doi: 10.1128/aac.32.3.403. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES